Psychedelic Therapy Access

Access to psychedelic therapies remains limited in the U.S., with only a few states like Oregon and Colorado taking steps toward legalization. The journey to federal approval for treatments like psilocybin therapy is ongoing, with significant trials expected to culminate around 2026. Funding remains a challenge, as the field relies heavily on philanthropy, and aspiring researchers are encouraged to build expertise in related areas such as psychiatry or addiction to contribute effectively.